- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05118503
Personalized Patient and Caregiver Education After Stroke (MyStroke)
October 25, 2023 updated by: Christopher Favilla, University of Pennsylvania
This is a randomized pilot trial to evaluate the impact of a customizable stroke education app (vs standard of care discharge education) on patient satisfaction and education retention.
The impact of the intervention will be assessed 7, 30, and 90 days post-discharge.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Admitted for ischemic stroke
- At least 18 years old
- Patient or caregiver has access to a smart phone, tablet or computer
- Being discharged to either home or acute rehab
Exclusion Criteria:
- Patient or caregivers unable or unwilling to access the customized app with a smartphone, tablet, or computer
- Being discharged to a skilled nursing facility
- moderate-to-severe aphasia at the time of enrollment (as per NIHSS scoring) if patient is being enrolled without a caregiver
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Customized education app
A customized URL-based platform will present brief education videos addressing a patients stroke etiology, risk factors, stroke prevention medications, and post-stroke lifestyle issues.
This URL will be made available to the patient and caregiver.
|
Half of subjects will receive access to a customized app that will include brief educational videos that have been selected for each patient based on their medical history.
These videos will address stroke etiology, underlying risk factors, and stroke prevention medications.
|
|
Placebo Comparator: Standard of care discharge education
Standard discharge education is performed by the bedside nurse at the time of hospital discharge.
|
Half of subjects will be randomized to receive typical discharge education, per the institutional guidelines for standard of care education for stroke patients.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient satisfaction survey
Time Frame: Day 90
|
Likert-style survey assessing patient satisfaction and perception of the stroke education they received.
|
Day 90
|
|
Stroke Patient Education Retention (SPER) survey
Time Frame: Day 90
|
Validated measure of stroke patient education as it pertains to their stroke etiology and risk factors with scores of 0-10
|
Day 90
|
|
Stroke etiology awareness
Time Frame: Day 90
|
accurate knowledge of stroke etiology (0=incorrect; 1=correct)
|
Day 90
|
|
EuroQOL-VAS
Time Frame: Day 90
|
validated quality of life metric, with scores of 0-100
|
Day 90
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Stroke risk factor awareness, 90 days
Time Frame: Day 90
|
accurate knowledge of stroke risk factors (0=incorrect; 1=correct)
|
Day 90
|
|
Stroke risk factor awareness, 30 days
Time Frame: Day 30
|
accurate knowledge of stroke risk factors (0=incorrect; 1=correct)
|
Day 30
|
|
Stroke risk factor awareness. 7 days
Time Frame: Day 7
|
accurate knowledge of stroke risk factors (0=incorrect; 1=correct)
|
Day 7
|
|
Stroke prevention med awareness, 90 days
Time Frame: Day 90
|
accurate knowledge of stroke prevention medications (0=incorrect; 1=correct)
|
Day 90
|
|
Stroke prevention med awareness, 30 days
Time Frame: Day 30
|
accurate knowledge of stroke prevention medications (0=incorrect; 1=correct)
|
Day 30
|
|
Stroke prevention med awareness, 7 days
Time Frame: Day 7
|
accurate knowledge of stroke prevention medications (0=incorrect; 1=correct)
|
Day 7
|
|
Patient satisfaction, 30 days
Time Frame: Day 30
|
Likert-style survey assessing patient satisfaction and perception of the stroke education
|
Day 30
|
|
Patient satisfaction, 7 days
Time Frame: Day 7
|
Likert-style survey assessing patient satisfaction and perception of the stroke education
|
Day 7
|
|
SPER, 7 days
Time Frame: Day 7
|
Stroke Patient Education Retention (SPER) survey
|
Day 7
|
|
SPER, 30 days
Time Frame: Day 30
|
Stroke Patient Education Retention (SPER) survey
|
Day 30
|
|
Stroke etiology awareness
Time Frame: Day 7
|
accurate knowledge of stroke etiology (0=incorrect; 1=correct)
|
Day 7
|
|
Stroke etiology awareness
Time Frame: Day 30
|
accurate knowledge of stroke etiology (0=incorrect; 1=correct)
|
Day 30
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christopher Favilla, M.D., University of Pennsylvania
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2021
Primary Completion (Actual)
April 2, 2023
Study Completion (Actual)
April 2, 2023
Study Registration Dates
First Submitted
October 12, 2021
First Submitted That Met QC Criteria
November 1, 2021
First Posted (Actual)
November 12, 2021
Study Record Updates
Last Update Posted (Actual)
October 26, 2023
Last Update Submitted That Met QC Criteria
October 25, 2023
Last Verified
October 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 833723
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Customized education
-
Case Western Reserve UniversityNational Institute of Mental Health (NIMH)CompletedBipolar Disorder | Treatment NoncomplianceUnited States
-
HealthPartners InstituteAgency for Healthcare Research and Quality (AHRQ)CompletedDiabetes Mellitus
-
Ain Shams UniversityRecruiting
-
Wake Forest University Health SciencesNational Institute on Aging (NIA); Health Resources and Services Administration...Recruiting
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Enrolling by invitationCommunication | Patient Safety | Intensive Care Units | Patient Handoff | Healthcare TeamUnited States
-
Cairo UniversityUnknown
-
Sultan Abdulhamid Han Training and Research Hospital...CompletedDifficulty SwallowingTurkey (Türkiye)
-
Lei LiUnknownQuestionnaire | China | National Survey | Obstetrics and Gynecology | Workload | COVID-19 PandemicsChina
-
Ain Shams UniversityRecruiting
-
Cairo UniversityUnknown